SCHEMBL5965337

SCHEMBL5965337

CC(C)(C)OC(=O)N(CC(=O)O)C1CCCCCC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL583649 1.00
SCHEMBL6476990 1.00
Water SCHEMBL6244435 0.98
SCHEMBL992260 0.98
SCHEMBL361549 0.92
SCHEMBL646408 0.92 EPHX1 (0.40)
Hydrochloric Acid SCHEMBL3021166 0.90
SCHEMBL27510109 0.88 EPHX1 (0.39)
Proline SCHEMBL8381835 0.86
SCHEMBL6360303 0.86 CHRM2 (0.37)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12234225-B2 IL-17 ligands and uses thereof DICE ALPHA, INC. (US) 2025-02-25 US disclosed
CN-113874080-B IL-17A modulators and uses thereof 戴斯阿尔法公司 2024-09-27 CN disclosed
US-20230053746-A1 IL-17 LIGANDS AND USES THEREOF DICE MOLECULES SV, INC. 2023-02-23 US disclosed
US-11447468-B2 IL-17 ligands and uses thereof DICE ALPHA, INC. (US) 2022-09-20 US disclosed
CN-113874080-A IL-17A modulators and uses thereof 戴斯阿尔法公司 2021-12-31 CN disclosed
US-20200247785-A1 IL-17 Ligands And Uses Thereof DICE MOLECULES SV, INC. 2020-08-06 US disclosed
US-7071168-B2 Anti-cancer compounds and methods related thereto THE REGENTS OF THE UNIVERSITY OF COLORADO (US) 2006-07-04 US disclosed
US-20020183252-A1 Anti-cancer compounds and methods related thereto STEWART JOHN M (US) 2002-12-05 US disclosed
US-6388054-B1 AMINO ACID SEQUENCES OF ANTITUMOR AGENTS AND APOPTOSIS AGENTS NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2002-05-14 US disclosed
WO-2000011022-A1 ANTI-CANCER COMPOUNDS AND METHODS RELATED THERETO STEWART JOHN M (US) 2000-03-02 WO disclosed